Skip to main content
    P

    Plus Therapeutics Inc (PSTV)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.71
    -0.24 (-24.77%)

    Market Cap: $26.64M

    Last updated: Nov 16, 2026 at 4:00 PM ET

    Plus Therapeutics Inc (PSTV) Statistics

    Updated Nov 16, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Plus Therapeutics (PSTV) has a market cap of $26.64M and an enterprise value of $29.61M. It kept -859.47% of revenue as net income over the last 12 months. Its share count is up 76.09% from a year earlier.

    Total Valuation

    Enterprise value is 11.16% above the market cap, as debt exceeds cash.

    Market Cap$26.64M
    Enterprise Value$29.61M
    Close (Nov 16, 2026)$0.71

    Key Dates

    Last Earnings DateMay 15, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 9.68% in the quarter ended Sep 30, 2026 and shrank 1.86% a year over 2 years.

    Shares Outstanding7.57M
    Shares Change (YoY)+76.09%
    Shares Change (QoQ)+9.68%
    Share Count Growth (2Y CAGR)-1.86%

    Valuation Ratios

    The price to sales ratio is 1.5x. Its year-end P/S ranged from 1.3x to 37.7x from 2016 to 2024.

    P/S Ratio1.5x
    Forward P/S4.2x

    Price Statistics

    The stock is down 94.53% over 52 weeks and trades 57.23% below its 50-day average.

    Beta (1Y)1.96
    52-Week Change-94.53%
    1-Month Change-57.95%
    3-Month Change-76.79%
    6-Month Change-87.76%
    5-Year Change-99.76%
    10-Year Change-100.00%
    Total Return (1Y)-94.53%
    Total Return (3Y CAGR)-77.87%
    Total Return (5Y CAGR)-74.00%
    Max Drawdown (1Y)-96.83%
    Max Drawdown (3Y)-99.12%
    Sharpe Ratio (1Y)-2.35
    Correlation with SPY (1Y)0.22
    50-Day Average$1.66
    200-Day Average$4.31
    52-Week Range$2.90 to $23.43
    RSI (14 Days)32.3
    Average Volume (20 Days)2.25M

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 0.61x current liabilities.

    Current Ratio0.61x
    Quick Ratio0.60x

    Returns and Efficiency

    Return on invested capital is -827.77% over the last 12 months.

    Return on Assets (ROA)-248.54%
    Return on Invested Capital (ROIC)-827.77%
    Asset Turnover0.23x
    Receivables Turnover9.77x

    Scores

    PSTV has an Altman Z-Score of -70.28, in the distress zone below 1.81, and a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.

    Altman Z-Score-70.28
    Altman Z ZoneDistress
    Piotroski F-Score3 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $3.53M over the last 12 months is down 32.90% from the 12 months before.

    Revenue$3.53M
    Revenue Growth (YoY)-32.90%
    Gross Profit$3.53M
    Operating Income-$29.37M
    Pretax Income-$30.32M
    Net Income-$30.32M

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Cash and Equivalents$879.00K
    Total Debt$3.85M
    Net Debt$2.97M
    Net Debt Per Share$0.39
    Working Capital-$5.06M
    Shareholder Equity-$923.00K
    Tangible Book Value-$1.53M
    Total Assets$12.20M
    Total Liabilities$13.12M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $1.40M of capital spending, operating cash flow left -$28.70M of free cash flow.

    Operating Cash Flow-$27.30M
    Capital Expenditures$1.40M
    Free Cash Flow-$28.70M
    FCF Per Share-$4.17
    Depreciation and Amortization$572.00K

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -832.57%.

    Gross Margin100.00%
    Operating Margin-832.57%
    Pretax Margin-859.47%
    Net Margin-859.47%
    FCF Margin-813.46%

    Dividends and Yields

    PSTV does not pay a dividend. Its free cash flow yield is -530.60%.

    FCF Yield-530.60%
    Buyback Yield-30.30%
    Shareholder Yield-30.30%

    Stock Splits

    The last split was a 1-for-25 reverse split on Apr 2, 2026.

    Last Split DateApr 2, 2026
    Split TypeReverse split
    Split Ratio1:25

    Peer Position

    Against 5 similar companies, PSTV has the lowest ROIC.

    ROIC-827.77% vs -95.44% median
    Revenue Growth (Trailing 4 Quarters, YoY)-32.90% vs -100.00% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 91.62% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+91.62%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About PSTV

    What is PSTV's market cap?

    Plus Therapeutics has a market cap of $26.64M. Its enterprise value, which adds debt and subtracts cash, is $29.61M.

    How many shares of PSTV are outstanding?

    Plus Therapeutics has 7.57M shares outstanding. The count is up 76.09% from a year earlier.

    Does PSTV pay a dividend?

    No. Plus Therapeutics does not pay a dividend.

    How much debt does PSTV have?

    Plus Therapeutics has $3.85M of total debt and $879.00K of cash and equivalents, a net debt position of $2.97M.